1. Home
  2. SPRO vs KBSX Comparison

SPRO vs KBSX Comparison

Compare SPRO & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

SELL

Current Price

$0.94

Market Cap

67.0M

Sector

Health Care

ML Signal

SELL

Logo FST Corp. Ordinary Shares

KBSX

FST Corp. Ordinary Shares

SELL

Current Price

$1.40

Market Cap

61.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
SPRO
KBSX
Founded
2013
1976
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
67.0M
61.6M
IPO Year
2017
2024

Fundamental Metrics

Financial Performance
Metric
SPRO
KBSX
Price
$0.94
$1.40
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $5.33
$3.50
AVG Volume (30 Days)
★ 320.0K
5.4K
Earning Date
11-12-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 111.81
N/A
EPS
N/A
★ N/A
Revenue
★ $66,802,000.00
N/A
Revenue This Year
N/A
$18.93
Revenue Next Year
N/A
$13.80
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 39.24
N/A
52 Week Low
$0.95
$0.81
52 Week High
$3.08
$1.79

Technical Indicators

Market Signals
Indicator
SPRO
KBSX
Relative Strength Index (RSI) 34.32 41.36
Support Level N/A $1.12
Resistance Level $1.27 $1.21
Average True Range (ATR) 0.06 0.12
MACD -0.01 -0.02
Stochastic Oscillator 3.18 18.92

Price Performance

Historical Comparison
SPRO
KBSX

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: